Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Terumo Interventional Systems has launched its R2P NaviCross peripheral support catheter in the U.S., expanding its radial-to-peripheral portfolio. The new 200 cm length catheter features double-braided, stainless-steel construction for enhanced trackability and torque control in complex procedures. This addition complements Terumo's existing R2P portfolio, which includes the Destination Slender guiding sheath, SlenGuide guiding catheter, Misago self-expanding peripheral stent, and other specialized catheters. The device is specifically designed for treating peripheral artery disease (PAD) and critical limb ischemia through radial access procedures.
Terumo Interventional Systems ha lanciato il suo catetere di supporto periferico R2P NaviCross negli Stati Uniti, ampliando il suo portafoglio dal radiale al periferico. Il nuovo catetere di 200 cm presenta una costruzione in acciaio inossidabile a doppia treccia per una maggiore tracciabilità e controllo della coppia durante procedure complesse. Questa aggiunta complementa il portafoglio esistente R2P di Terumo, che include il rivestimento guida Destination Slender, il catetere guida SlenGuide, lo stent periferico autoadattabile Misago e altri cateteri specializzati. Il dispositivo è specificamente progettato per il trattamento della malattia arteriosa periferica (PAD) e dell'ischemia critica degli arti tramite procedure di accesso radiale.
Terumo Interventional Systems ha lanzado su catéter de soporte periférico R2P NaviCross en los EE.UU., ampliando su cartera de radial a periférico. El nuevo catéter de 200 cm cuenta con una construcción de acero inoxidable trenzado doble para una mejor capacidad de seguimiento y control de torsión en procedimientos complejos. Esta adición complementa la cartera existente de R2P de Terumo, que incluye la funda guía Destination Slender, el catéter guía SlenGuide, el stent periférico autoexpandible Misago y otros catéteres especializados. El dispositivo está diseñado específicamente para tratar la enfermedad arterial periférica (PAD) y la isquemia crítica de las extremidades a través de procedimientos de acceso radial.
테루모 인터벤셔널 시스템즈는 미국에서 R2P NaviCross 말초 지원 카테터를 출시하여 레이디얼-말초 포트폴리오를 확장했습니다. 새로운 200cm 길이의 카테터는 복잡한 절차에서 향상된 궤적 추적성과 토크 제어를 위해 이중 브레이드 스테인리스 스틸 구조를 특징으로 합니다. 이 추가 장치는 테루모의 기존 R2P 포트폴리오를 보완하며, 여기에는 Destination Slender 안내용 시스, SlenGuide 안내용 카테터, Misago 자가 확장 말초 스텐트 및 기타 전문 카테터가 포함됩니다. 이 장치는 레이디얼 접근 절차를 통해 말초 동맥 질환(PAD) 및 비판적인 사지 허혈을 치료하기 위해 특별히 설계되었습니다.
Terumo Interventional Systems a lancé son cathéter de soutien périphérique R2P NaviCross aux États-Unis, élargissant ainsi son portefeuille allant du radial au périphérique. Le nouveau cathéter de 200 cm présente une construction en acier inoxydable à deux tresses pour une meilleure traçabilité et un contrôle du couple lors de procédures complexes. Cet ajout complète le portefeuille R2P existant de Terumo, qui comprend le gaine de guidage Destination Slender, le cathéter de guidage SlenGuide, le stent périphérique auto-expansible Misago et d'autres cathéters spécialisés. L'appareil est conçu spécifiquement pour traiter la maladie artérielle périphérique (PAD) et l'ischémie critique des membres par des procédures d'accès radial.
Terumo Interventional Systems hat seinen R2P NaviCross peripheren Unterstützungskatheter in den USA eingeführt und sein Portfolio von radial zu peripher erweitert. Der neue 200 cm lange Katheter besteht aus doppelt geflochtenem, rostfreiem Stahl, was eine verbesserte Nachverfolgbarkeit und Drehmomentkontrolle bei komplexen Verfahren ermöglicht. Diese Ergänzung ergänzt das bestehende R2P-Portfolio von Terumo, das die Destination Slender Führungs-Hülse, den SlenGuide Führungs-Katheter, das Misago selbstexpandierende periphere Stent und andere spezialisierte Katheter umfasst. Das Gerät ist speziell zur Behandlung der peripheren arteriellen Verschlusskrankheit (PAD) und kritischer Gliedmaßenischämie durch radiale Zugangsverfahren konzipiert.
- Launch of new R2P NaviCross catheter expands product portfolio
- Product addresses growing market demand for PAD treatment solutions
- Enhanced technical capabilities with double-braided stainless-steel design
- None.
– Provides interventionalists with optimal product choices for more complex radial-to-peripheral procedures –
"Our customers have been asking for a longer length, high-performance NaviCross support catheter, and I am proud to say we answered the need by delivering R2P NaviCross to the market, further enhancing our radial-to-peripheral portfolio," said Ghada Farah, Division President, Terumo Interventional Systems. "R2P NaviCross solidifies Terumo's leadership in radial access, particularly as the demand for procedures to treat peripheral artery disease (PAD) and critical limb ischemia continues to rise."
"With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more procedures from a radial approach," said Michael J. Martinelli, MD, FACC, FSCAI and Chief Medical Officer, Terumo Medical Corporation. "Additionally, the double-braided, stainless-steel design of the R2P NaviCross catheter makes it possible to access and cross simple-to-complex lesions above and below the knee."
The new 200 cm R2P NaviCross catheter rounds out the existing R2P portfolio, including the R2P Destination Slender™ guiding sheath, R2P SlenGuide™ guiding catheter, R2P Misago® self-expanding peripheral stent, and R2P Metacross™ RX and R2P Crosstella™ RX dilatation catheters – giving physicians the confidence to complete almost any PAD procedure from the wrist.
About Terumo Interventional Systems
Terumo Interventional Systems (TIS), a division of Terumo Corporation, is a market leader in minimally invasive entry site management, lesion access, and therapeutic intervention. TIS offers a complete, solution-based product portfolio used in advanced coronary, peripheral and endovascular treatments with strategic initiatives in Transradial Access, Complex Coronary Intervention, Peripheral Artery Disease and Embolotherapy. TIS combines innovative research and development with a deep market understanding to create a pipeline of industry-leading devices that deliver clinical value, economic benefit, and enhanced patient outcomes.
About Terumo
Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for over 100 years. Based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/terumo-interventional-systems-announces-launch-of-its-r2p-navicross-peripheral-support-catheter-302316685.html
SOURCE Terumo Medical Corporation
FAQ
What is the new product launched by Terumo (TRUMY) in December 2024?
What are the key features of Terumo's (TRUMY) new R2P NaviCross catheter?
What medical conditions does Terumo's (TRUMY) R2P NaviCross catheter treat?
